Calcium Chloride

CHEMBL1200668 Phase 4 ได้รับการอนุมัติ Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
111.0 g/mol
LogP
Phase
4

An injectable calcium salt used in emergency medicine to treat severe hypocalcemia, hyperkalemia, and calcium channel blocker overdose. It provides a higher concentration of elemental calcium per volume than calcium gluconate, making it preferred in critical settings. Extravasation can cause severe tissue damage, requiring careful intravenous administration.

น้ำหนักโมเลกุล

110.9800 g/mol

TPSA

0.00 Ų

ด้านการรักษา

กลไกการออกฤทธิ์

Blocks L-type voltage-gated calcium channels in vascular smooth muscle and cardiac myocytes, reducing calcium influx during depolarization. This produces vasodilation, decreased myocardial contractility, and reduced heart rate.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

กลไก

Blocks L-type voltage-gated calcium channels in vascular smooth muscle and cardiac myocytes, reducing calcium influx during depolarization. This produces vasodilation, decreased myocardial contractility, and reduced heart rate.

โครงสร้าง 2 มิติ

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

[Ca+2].[Cl-].[Cl-]

InChI

InChI=1S/Ca.2ClH/h;2*1H/q+2;;/p-2

Molecular Formula

CaCl2

HBD / HBA

- / 2

พันธะที่หมุนได้

0

อะตอมหนัก

3

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

คำถามที่พบบ่อย

An injectable calcium salt used in emergency medicine to treat severe hypocalcemia, hyperkalemia, and calcium channel blocker overdose. It provides a higher concentration of elemental calcium per volume than calcium gluconate, making it preferred in critical settings. Extravasation can cause severe tissue damage, requiring careful intravenous administration.

Blocks L-type voltage-gated calcium channels in vascular smooth muscle and cardiac myocytes, reducing calcium influx during depolarization. This produces vasodilation, decreased myocardial contractility, and reduced heart rate.

Yes, Calcium Chloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200668. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 5284359. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

ข้อจำกัดความรับผิดชอบทางการแพทย์

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.